Case report: Additional use of hydroxychloroquine in treatment‐resistant recurrent cerebral infarctions with antiphospholipid antibody syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Case report: Additional use of hydroxychloroquine in treatment‐resistant recurrent cerebral infarctions with antiphospholipid antibody syndrome

Published:2024-02 Issue:2 Volume:27 Page:
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J of Rheum Dis

Author:

Isogai Shuntaro¹²,Mizuno Masayuki³,Uehara Koji¹²,Okita Kenji³,Naniwa Taio¹²^ORCID

Affiliation:

1. Division of Rheumatology, Department of Internal Medicine Nagoya City University Hospital Nagoya Aichi Japan

2. Department of Respiratory Medicine, Allergy and Clinical Immunology Nagoya City University Graduate School of Medical Sciences Nagoya Aichi Japan

3. Department of Neurology Nagoya City University Graduate School of Medical Sciences Nagoya Aichi Japan

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.15056

Reference15 articles.

1. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

2. EULAR recommendations for the management of antiphospholipid syndrome in adults

3. Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients

4. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome

5. The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP